Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 266, Issue 11, pp 1719–1726 | Cite as

Subjective audiological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors affecting hearing levels

  • Oğuzhan Dikici
  • Nuray Bayar MulukEmail author
  • Aliye Kapukiran Tosun
  • Ihsan Ünlüsoy
Otology

Abstract

We investigated hearing functions in patients with rheumatoid arthritis (RA) using audiological tests and transient evoked otoacoustic emissions (TEOAEs). The study group consisted of 20 adult patients with RA (7 males, 13 females); 20 adult healthy subjects without RA (7 males, 13 females) were recruited as controls. All patients were evaluated by pure tone audiometry, high frequency audiometry, tympanometry and TEOAEs. There were no statistical differences between the study and control groups with respect to the pure tone and high frequency audiometries. TEOAE results of 1.0–2.0 kHz % and of 1.5 and 3.0 kHz amplitude values were significantly lower, and ipsilateral stapes reflex threshold value at 1.0 kHz was significantly higher in the study group when compared to respective values in the control group. In elderly patients and those with longer disease duration, RA nodules and higher methotrexate cumulative doses, hearing thresholds increased and TEOAE values decreased. In active stage of the disease, hearing thresholds diminished and in higher Brinkman Index values, TEOAE values decreased. Compliance values decreased in patients with higher Ritchie Articular Index, C-reactive protein, erythrocyte sedimentation rate and platelet counts, and longer disease duration. Sensorineural hearing loss is generally observed in patients with RA, and this condition may be detected by TEOAEs in an early period of the disease. Inflammation during the active stage of the disease and the subsequent fibrosis may cause conductive hearing loss of varying degrees. In those patients detected as having initiation of TEOAE decrease, vasodilator treatment and antioxidant drugs may be useful in protecting the inner ear.

Keywords

Rheumatoid arthritis (RA) Hearing levels Pure tone audiometry High frequency audiometry Transient evoked otoacoustic emissions (TEOAEs) 

Notes

Acknowledgments

The authors declare that there was no sponsor for this research and that there is no financial relationship to disclose.

Conflict of interest statement

The authors also have no conflicts of interest to declare.

References

  1. 1.
    Takatsu M, Higaki M, Kinoshita H et al (2005) Ear involvement in patients with rheumatoid arthritis. Otol Neurotol 26:755–761. doi: 10.1097/01.mao.0000178138.19848.bd PubMedCrossRefGoogle Scholar
  2. 2.
    Rigual NR (1987) Otolaryngologic manifestations of rheumatoid arthritis. Ear Nose Throat J 66:18–22Google Scholar
  3. 3.
    Coletti V, Fiorino FG, Bruni L et al (1997) Middle ear mechanics in subjects with rheumatoid arthritis. Audiology 36:136–146CrossRefGoogle Scholar
  4. 4.
    Frade C, Martin C (1998) Diagnostic value of the multi-frequency tympanometry in active rheumatoid arthritis. Auris Nasus Larynx 25:131–136. doi: 10.1016/S0385-8146(98)00020-0 PubMedCrossRefGoogle Scholar
  5. 5.
    Ozcan M, Karakus MF, Gunduz OH et al (2002) Hearing loss and middle ear involvement in rheumatoid arthritis. Rheumatol Int 22:16–19. doi: 10.1007/s00296-002-0185-z PubMedCrossRefGoogle Scholar
  6. 6.
    Raut VV, Cullen J, Cathers G (2001) Hearing loss in rheumatoid arthritis. J Otolaryngol 30:289–294. doi: 10.2310/7070.2001.19580 PubMedCrossRefGoogle Scholar
  7. 7.
    Kastanioudakis I, Skevas A, Danielidis V et al (1995) Inner ear involvement in rheumatoid arthritis: a prospective clinical study. J Laryngol Otol 109:713–718. doi: 10.1017/S0022215100131135 PubMedCrossRefGoogle Scholar
  8. 8.
    Kakani RS, Mehra YN, Deodhar SD et al (1990) Audiovestibular functions in rheumatoid arthritis. J Otolaryngol 19:100–102PubMedGoogle Scholar
  9. 9.
    Magaro M, Zoli A, Altomonte L et al (1990) Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheumatol 8:487–490PubMedGoogle Scholar
  10. 10.
    Elwany S, El Garf A, Kamel T (1986) Hearing and middle ear function in rheumatoid arthritis. J Rheumatol 13:878–881PubMedGoogle Scholar
  11. 11.
    Reiter D, Konkle DF, Myers AR et al (1980) Middle ear immittance in rheumatoid arthritis. Arch Otolaryngol 106:114–117PubMedGoogle Scholar
  12. 12.
    Bayazit YA, Yilmaz M, Gunduz B et al (2007) Distortion product otoacoustic emission findings in Behçet’s disease and rheumatoid arthritis. ORL J Otorhinolaryngol Relat Spec 69(4):233–238. doi: 10.1159/000101544 PubMedGoogle Scholar
  13. 13.
    Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum 31:315–324. doi: 10.1002/art.1780310302 PubMedCrossRefGoogle Scholar
  14. 14.
    Ritchie DM, Boyle JA, Mclnnes JM et al (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37:393–406PubMedGoogle Scholar
  15. 15.
    Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 140:659–662PubMedGoogle Scholar
  16. 16.
    Lipsky PE (1987) Rheumatoid arthritis. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wılson JD, Martin JB, Fauci AS (eds) Harrison’s principles of internal medicine 2, vol 2, 11th edn. McGraw-Hill, New York, pp 1423–1428Google Scholar
  17. 17.
    Green DS (1983) Pure tone air conduction testing. In: Katz J (ed) Handbook of clinical audiology, 2nd edn. Waverly Press, Baltimore, pp 98–108Google Scholar
  18. 18.
    Nomura K, Nakao M, Yano E (2005) Hearing loss associated with smoking and occupational noise exposure in a Japanese metal working company. Int Arch Occup Environ Health 78(3):178–184. doi: 10.1007/s00420-005-0604-z PubMedCrossRefGoogle Scholar
  19. 19.
    52nd WMA General Assembly (2000) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284:3043–3049. doi: 10.1001/jama.284.23.3043
  20. 20.
    Siamopoulou-Mavridou A, Skevas A, Moutsopoulos HM (1990) Middle ear function in patients with juvenile chronic arthritis. Ann Rheum Dis 49:620–623. doi: 10.1136/ard.49.8.620 PubMedCrossRefGoogle Scholar
  21. 21.
    Heyworth T, Liyanage SP (1972) A pilot survey of hearing loss in patients with rheumatoid arthritis. Scand J Rheumatol 1:81–83. doi: 10.3109/03009747209103000 PubMedCrossRefGoogle Scholar
  22. 22.
    Gussen R (1977) Atypical ossicle joint lesions in rheumatoid arthritis with sicca syndrome (Sjogren syndrome). Arch Otolaryngol 103:284–286PubMedGoogle Scholar
  23. 23.
    Seçkin U, Ozoran K, Ikinciogullari A et al (2000) Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatol Int 19:203–204. doi: 10.1007/s002960000054 PubMedCrossRefGoogle Scholar
  24. 24.
    Coutinho MM, Duarte I (2002) Hydroxychloroquine ototoxicity in a child with idiopathic pulmonary haemosiderosis. Int J Pediatr Otorhinolaryngol 62:53–57. doi: 10.1016/S0165-5876(01)00592-4 PubMedCrossRefGoogle Scholar
  25. 25.
    Wen B, Liang C, He G et al (2005) A randomized controlled trail on vasodilators and steroids for sudden sensorineural hearing loss. Lin Chuang Er Bi Yan Hou Ke Za Zhi 19(16):724–726PubMedGoogle Scholar
  26. 26.
    Jurkiewicz D, Kantor I, Usowski J (2006) Assessment of betahistine dihydrochloride effectiveness in the treatment of disturbance of balance system, based on analysis of doctors and patients questionnaires results. Pol Merkur Lekarski 21(Suppl 1):3–12PubMedGoogle Scholar
  27. 27.
    Sheehy JL (1960) Vasodilator therapy in sensory-neural hearing loss. Trans Am Laryngol Rhinol Otol Soc 1960:570–602PubMedGoogle Scholar
  28. 28.
    García Callejo FJ, Conill Tobías N, Muñoz Fernández N et al (2007) Hearing impairment in patients with rheumatoid arthritis. Acta Otorrinolaringol Esp 58(6):232–238. doi: 10.1016/S0001-6519(07)74919-1 PubMedCrossRefGoogle Scholar
  29. 29.
    Murdin L, Patel S, Walmsley J et al (2008) Hearing difficulties are common in patients with rheumatoid arthritis. Clin Rheumatol 27(5):637–640. doi: 10.1007/s10067-007-0802-z PubMedCrossRefGoogle Scholar
  30. 30.
    Fechter L, Thorne P, Nuttall A (1987) Effects of carbon monoxide on cochlear electrophysiology and blood flow. Hear Res 27:37–45. doi: 10.1016/0378-5955(87)90024-4 PubMedCrossRefGoogle Scholar
  31. 31.
    Cruickshanks KJ, Klein R, Klein BEK et al (1998) Cigarette smoking and hearing loss. The epidemiology of hearing loss study. JAMA 279(21):1715–1719. doi: 10.1001/jama.279.21.1715 PubMedCrossRefGoogle Scholar
  32. 32.
    Lantz J, Petrak M, Prigge L (2004) High-frequency immittance with infants. Using the 1000-Hz probe for immittance measurements in infants. Hear J 57(10). http://www.msrwest.com/Resources/1K_Probe_Tone.pdf (Accessed 15 Jan 2009)
  33. 33.
    Marchant CD, McMillan PM, Shurin PA et al (1986) Objective diagnosis of otitis media in early infancy by tympanometry and ipsilateral acoustic reflex thresholds. J Pediatr 109(4):590–595. doi: 10.1016/S0022-3476(86)80218-9 PubMedCrossRefGoogle Scholar
  34. 34.
    Shurin PA, Pelton SI, Finkelstein J (1977) Tympanometry in the diagnosis of middle-ear effusion. N Engl J Med 296(8):412–417PubMedCrossRefGoogle Scholar
  35. 35.
    Sutton G, Baldwin M, Brooks D, et al (2002) Tympanometry in neonates and infants under 4 months: a recommended test protocol. The Newborn Hearing Screening Programme, UK. http://www.nhsp.info
  36. 36.
    Zhuravskii SG, Aleksandrova LA, Sirot VS et al (2004) Natural antioxidant l-carnosine inhibits LPO intensification in structures of the auditory analyzer under conditions of chronic exposure to aminoglycoside antibiotics. Bull Exp Biol Med 138(10):361–364. doi: 10.1007/s10517-004-0012-5 PubMedCrossRefGoogle Scholar
  37. 37.
    Li G, Sha SH, Zotova E et al (2002) Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab Invest 82:585–596. doi: 10.1038/labinvest.3780453 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Oğuzhan Dikici
    • 1
  • Nuray Bayar Muluk
    • 1
    • 2
    Email author
  • Aliye Kapukiran Tosun
    • 3
  • Ihsan Ünlüsoy
    • 3
  1. 1.ENT Department, Faculty of MedicineKırıkkale UniversityKırıkkaleTurkey
  2. 2.Çankaya/AnkaraTurkey
  3. 3.Department of Physical Medicine and Rehabilitation, Faculty of MedicineKırıkkale UniversityKırıkkaleTurkey

Personalised recommendations